Basic info
Industry
biotechnology research
Sectors
Biotechnology
genomic technologies
Artificial Intelligence
machine learning
Machine Learning
Analytics
single-cell biology
Therapeutics
software engineering
cancer
high-dimensional statistics
immunology
Date founded
2019
Funding rounds raised
Total raised
$215M
from 10 investors over 10 rounds
I
Immunai raised $215M on October 27, 2021
Investors: Meron Capital, Koch Disruptive Technologies, 8VC and ICon Professional Services
I
Immunai raised $60M on February 11, 2021
Investors: Meron Capital, TLV Partners, Catalio Capital Management and Dexcel Pharma
I
Immunai raised $20M on May 14, 2020
Investors: Meron Capital and TLV Partners